231 related articles for article (PubMed ID: 25886495)
1. The role of clinically significant portal hypertension in hepatic resection for hepatocellular carcinoma patients: a propensity score matching analysis.
He W; Zeng Q; Zheng Y; Chen M; Shen J; Qiu J; Chen M; Zou R; Liao Y; Li Q; Wu X; Li B; Yuan Y
BMC Cancer; 2015 Apr; 15():263. PubMed ID: 25886495
[TBL] [Abstract][Full Text] [Related]
2. Hepatic resection is safe and effective for patients with hepatocellular carcinoma and portal hypertension.
Zhong JH; Li H; Xiao N; Ye XP; Ke Y; Wang YY; Ma L; Chen J; You XM; Zhang ZY; Lu SD; Li LQ
PLoS One; 2014; 9(9):e108755. PubMed ID: 25268959
[TBL] [Abstract][Full Text] [Related]
3. Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients.
Giannini EG; Savarino V; Farinati F; Ciccarese F; Rapaccini G; Marco MD; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
Liver Int; 2013 Nov; 33(10):1594-600. PubMed ID: 23654354
[TBL] [Abstract][Full Text] [Related]
4. Resection versus ablation in hepatitis B virus-related hepatocellular carcinoma patients with portal hypertension: A propensity score matching study.
Qiu J; Zheng Y; Shen J; Zeng QA; Zou R; Liao Y; He W; Li Q; Chen G; Li B; Yuan Y
Surgery; 2015 Nov; 158(5):1235-43. PubMed ID: 25958066
[TBL] [Abstract][Full Text] [Related]
5. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma.
Ishizawa T; Hasegawa K; Aoki T; Takahashi M; Inoue Y; Sano K; Imamura H; Sugawara Y; Kokudo N; Makuuchi M
Gastroenterology; 2008 Jun; 134(7):1908-16. PubMed ID: 18549877
[TBL] [Abstract][Full Text] [Related]
6. Influence of clinically significant portal hypertension on surgical outcomes and survival following hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis.
Choi SB; Kim HJ; Song TJ; Ahn HS; Choi SY
J Hepatobiliary Pancreat Sci; 2014 Sep; 21(9):639-47. PubMed ID: 24867654
[TBL] [Abstract][Full Text] [Related]
7. Predictive factors for long-term survival in patients with clinically significant portal hypertension following resection of hepatocellular carcinoma.
Choi GH; Park JY; Hwang HK; Kim DH; Kang CM; Choi JS; Park YN; Kim DY; Ahn SH; Han KH; Chon CY; Lee WJ
Liver Int; 2011 Apr; 31(4):485-93. PubMed ID: 21382158
[TBL] [Abstract][Full Text] [Related]
8. Is portal hypertension a contraindication to hepatic resection?
Cucchetti A; Ercolani G; Vivarelli M; Cescon M; Ravaioli M; Ramacciato G; Grazi GL; Pinna AD
Ann Surg; 2009 Dec; 250(6):922-8. PubMed ID: 19855258
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the Outcomes of Patients with Hepatocellular Carcinoma and Portal Hypertension After Liver Resection Versus Radiofrequency Ablation.
Harada N; Shirabe K; Maeda T; Kayashima H; Takaki S; Maehara Y
World J Surg; 2016 Jul; 40(7):1709-19. PubMed ID: 26911609
[TBL] [Abstract][Full Text] [Related]
10. Laparoscopic liver resection for hepatocellular carcinoma complicated with significant portal hypertension: A propensity score-matched survival analysis.
Guo ZY; Hong Y; Tu B; Cheng Y; Wang XM
Hepatobiliary Pancreat Dis Int; 2023 Aug; 22(4):358-365. PubMed ID: 35370090
[TBL] [Abstract][Full Text] [Related]
11. Safety and feasibility of laparoscopic liver resection for hepatocellular carcinoma with clinically significant portal hypertension: a propensity score-matched study.
Zheng J; Feng X; Liang Y; Cai J; Shi Z; Kirih MA; Tao L; Liang X
Surg Endosc; 2021 Jul; 35(7):3267-3278. PubMed ID: 32632488
[TBL] [Abstract][Full Text] [Related]
12. Influence of clinically significant portal hypertension on hepatectomy for hepatocellular carcinoma: a meta-analysis.
Tang YH; Zhu WJ; Wen TF
Asian Pac J Cancer Prev; 2014; 15(4):1649-54. PubMed ID: 24641383
[TBL] [Abstract][Full Text] [Related]
13. Impact of concurrent splenectomy and esophagogastric devascularization on surgical outcomes of partial hepatectomy for hepatocellular carcinoma in patients with clinically significant portal hypertension: A multicenter propensity score matching analysis.
Chen ZL; Yao LQ; Pu JL; Wu H; Xu XF; Chen TH; Zhou YH; Wang H; Chen ZY; Sun LY; Diao YK; Zhong JH; Lau WY; Pawlik TM; Huang DS; Shen F; Liang YJ; Yang T
Eur J Surg Oncol; 2022 May; 48(5):1078-1086. PubMed ID: 34838392
[TBL] [Abstract][Full Text] [Related]
14. [The adverse effect of indirectly diagnosed portal hypertension on the complications and prognosis after hepatic resection of hepatocellular carcinoma].
An M; Park JW; Shin JA; Choi JI; Kim TH; Kim SH; Lee WJ; Park SJ; Hong EK; Kim CM
Korean J Hepatol; 2006 Dec; 12(4):553-61. PubMed ID: 17237634
[TBL] [Abstract][Full Text] [Related]
15. Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma.
Zhong JH; Ke Y; Gong WF; Xiang BD; Ma L; Ye XP; Peng T; Xie GS; Li LQ
Ann Surg; 2014 Aug; 260(2):329-40. PubMed ID: 24096763
[TBL] [Abstract][Full Text] [Related]
16. Prognosis and safety of laparoscopic hepatectomy for BCLC stage 0/A hepatocellular carcinoma with clinically significant portal hypertension: a multicenter, propensity score-matched study.
Xia F; Zhang Q; Ndhlovu E; Zheng J; Yuan M; Gao H; Xia G
Surg Endosc; 2024 Feb; 38(2):799-812. PubMed ID: 38062182
[TBL] [Abstract][Full Text] [Related]
17. Microwave ablation versus laparoscopic resection for hepatocellular carcinoma in patients with clinically significant portal hypertension: a propensity score-matched study of postoperative liver decompensation.
Yu H; Zhao F; Men X; Zhu H; Yan J; Liu Z; Liu Q; Feng Y; Wang L; Meng M; Zhu Q; Zhao X
Eur Radiol; 2024 May; 34(5):3226-3235. PubMed ID: 37875593
[TBL] [Abstract][Full Text] [Related]
18. Resection vs. ablation for alpha-fetoprotein positive hepatocellular carcinoma within the Milan criteria: a propensity score analysis.
He W; Li B; Zheng Y; Zou R; Shen J; Cheng D; Tao Q; Liu W; Li Q; Chen G; Yuan Y
Liver Int; 2016 Nov; 36(11):1677-1687. PubMed ID: 27187721
[TBL] [Abstract][Full Text] [Related]
19. Is hepatectomy feasible for hepatocellular carcinoma patients with clinically significant portal hypertension and beyond the Milan criteria?
Lu Z; Wei X; Tan L; Xiang B; Gong W
Eur J Surg Oncol; 2023 Nov; 49(11):107073. PubMed ID: 37748278
[TBL] [Abstract][Full Text] [Related]
20. Combination of albumin-bilirubin grade and clinically significant portal hypertension predicts the prognosis of patients with hepatocellular carcinoma after liver resection.
Qin L; Li C; Xie F; Wang Z; Wen T
Biosci Trends; 2021 Mar; 15(1):41-49. PubMed ID: 33627573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
